• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Wellcome Open Res . Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya

tetano

Editor, Senior Moderator
Wellcome Open Res


. 2022 Feb 23;7:69.
doi: 10.12688/wellcomeopenres.17661.1. eCollection 2022.
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya


James Nyagwange[SUP] #[/SUP][SUP] 1 [/SUP], Leonard Ndwiga[SUP] #[/SUP][SUP] 1 [/SUP], Kelvin Muteru[SUP] #[/SUP][SUP] 1 [/SUP], Kevin Wamae[SUP] 1 [/SUP], James Tuju[SUP] 1 [/SUP], Covid Testing Team[SUP] 1 [/SUP], Bernadette Kutima[SUP] 1 [/SUP], John Gitonga[SUP] 1 [/SUP], Henry Karanja[SUP] 1 [/SUP], Daisy Mugo[SUP] 1 [/SUP], Kadondi Kasera[SUP] 2 [/SUP], Patrick Amoth[SUP] 2 [/SUP], Nickson Murunga[SUP] 1 [/SUP], Lawrence Babu[SUP] 1 [/SUP], Edward Otieno[SUP] 1 [/SUP], George Githinji[SUP] 1 [/SUP], D J Nokes[SUP] 1 [/SUP], Benjamin Tsofa[SUP] 1 [/SUP], Benedict Orindi[SUP] 1 [/SUP], Edwine Barasa[SUP] 1 [/SUP], George Warimwe[SUP] 1 [/SUP], Charles N Agoti[SUP] 1 [/SUP], Philip Bejon[SUP] 1 [/SUP], Lynette Isabella Ochola-Oyier[SUP] 1 [/SUP]



Affiliations

Abstract

Background: There are limited studies in Africa describing the epidemiology, clinical characteristics and serostatus of individuals tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We tested routine samples from the Coastal part of Kenya between 17 [SUP]th[/SUP] March 2020 and 30 [SUP]th[/SUP] June 2021. Methods: SARS-CoV-2 infections identified using reverse transcription polymerase chain reaction (RT-PCR) and clinical surveillance data at the point of sample collection were used to classify as either symptomatic or asymptomatic. IgG antibodies were measured in sera samples, using a well validated in-house enzyme-linked immunosorbent assay (ELISA). Results: Mombasa accounted for 56.2% of all the 99,694 naso-pharyngeal/oro-pharyngeal swabs tested, and males constituted the majority tested (73.4%). A total of 7737 (7.7%) individuals were SARS-CoV-2 positive by RT-PCR. The majority (i.e., 92.4%) of the RT-PCR positive individuals were asymptomatic. Testing was dominated by mass screening and travellers, and even at health facility level 91.6% of tests were from individuals without symptoms. Out of the 97,124 tests from asymptomatic individuals 7,149 (7%) were positive and of the 2,568 symptomatic individuals 588 (23%) were positive. In total, 2458 serum samples were submitted with paired naso-pharyngeal/oro-pharyngeal samples and 45% of the RT-PCR positive samples and 20% of the RT-PCR negative samples were paired with positive serum samples. Symptomatic individuals had significantly higher antibody levels than asymptomatic individuals and become RT-PCR negative on repeat testing earlier than asymptomatic individuals. Conclusions: In conclusion, the majority of SARS-CoV-2 infections identified by routine testing in Coastal Kenya were asymptomatic. This reflects the testing practice of health services in Kenya, but also implies that asymptomatic infection is very common in the population. Symptomatic infection may be less common, or it may be that individuals do not present for testing when they have symptoms.

Keywords: COVID-19; ELISA; RT-PCR; SARS-CoV-2; clinical characteristics; epidemiology; serology.
 
Back
Top Bottom